日本与我国台湾地区药品不良反应损害救济基金制度的比较及对我国的启示

发布时间：2018-08-04 16:12

【摘要】：目的:为构建我国药品不良反应损害(简称"药害")救济基金制度提供参考。方法:借鉴日本和我国台湾地区的药害救济制度,从基金设立的法律依据、主管机构性质、筹资来源、筹资比例和救济力度等方面进行对比研究,并对我国药害救济基金制度的构建提出建议。结果与结论:日本与我国台湾地区的药害救济基金均依法建立,但因行政管理制度、筹资来源、筹资比例和救济力度均有不同,在筹资模式各要素中呈现出某些共性(如均设立了相关法律、主管机构与其卫生部门的合作关系)与特异点(如基金主管机构性质,日本为独立行政法人、我国台湾地区为独立财团法人等)。我国建立药害救济基金制度时应加快推进相关立法,政府应合理安排基金管理机构,分阶段循序渐进建立药害救济基金,增强公众对药害救济基金的认知,建立以企业缴费为主的多元化筹资途径。
[Abstract]:Objective: to provide a reference for establishing the relief fund system of adverse drug reaction damage in China. Methods: a comparative study was carried out on the legal basis of the establishment of the fund, the nature of the competent agency, the source of financing, the proportion of financing and the relief strength, and so on, using the drug disaster relief system of Japan and Taiwan for reference. Some suggestions are put forward on the construction of the fund system of drug disaster relief in China. Results & conclusion: the drug disaster relief fund in Japan and Taiwan was established according to law, but the administrative system, the source of financing, the proportion of financing and the strength of relief were different. There are certain commonalities among the elements of the funding model (for example, the establishment of relevant laws, cooperation between the competent authorities and their health sectors) and special points (such as the nature of the fund authority and the fact that Japan is an independent administrative legal person), The Taiwan area of our country is an independent financial corporation and so on. In order to enhance the public's understanding of the fund, the government should arrange the fund management organization reasonably, set up the fund step by step, and strengthen the public's understanding of the fund. To establish the enterprise payment-based diversification of funding channels.
【作者单位】：中国药科大学国际医药商学院;
【分类号】：R951

【参考文献】